OTULIN and osteosarcoma: In the present study, we found that OTULIN can act as a key molecule in promoting cisplatin resistance; this cisplatin-dependent upregulation of OTULIN expression markedly decreased the sensitivity of osteosarcoma cells to cisplatin-induced cell death.